id,agency_id,title,docket_type,last_modified,object_id
DEA_FRDOC_0001,DEA,Recently Posted DEA Rules and Notices,Rulemaking,2026-03-10T12:55:22Z,0b0000648025b551
DEA-2023-0057,DEA,Definition of ‘‘Cannabimimetic Agents’’ and Assignment of an Administration Controlled Substances Code Number for All ‘‘Cannabimimetic Agents’’ (DEA368),Rulemaking,2026-01-20T18:44:45Z,0b00006485945c83
DEA-2026-0133,DEA,Schedules of Controlled Substances: Placement of 2-Fluorodeschloroketamine in Schedule I (DEA1442),Rulemaking,2026-01-20T18:39:12Z,0b000064b9161bed
DEA-2025-0075,DEA,Placement of 4-Fluoroamphetamine in Schedule I (DEA1180),Rulemaking,2026-01-16T15:16:59Z,0b000064b8dc49a1
DEA-2023-0029,DEA,Telemedicine Prescribing of Controlled Substances (DEA407),Rulemaking,2026-01-12T22:00:12Z,0b00006485728671
DEA-2024-0118,DEA,Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I (DEA1337),Rulemaking,2026-01-12T21:58:59Z,0b00006486732eab
DEA-2023-0147,DEA,Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I (DEA1143),Rulemaking,2026-01-05T20:10:17Z,0b0000648613cdb2
DEA-2025-0852,DEA,Schedules of Controlled Substances: Placement of CUMYL-PEGACLONE in Schedule I (DEA1511),Rulemaking,2026-01-05T13:16:32Z,0b000064b90c539c
DEA-2025-0918,DEA,"Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act (DEA1604)",Rulemaking,2026-01-05T13:16:18Z,0b000064b90dd26c
DEA-2025-0654,DEA,"Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2026",Rulemaking,2025-12-16T20:07:46Z,0b000064b909f13a
DEA-2025-0885,DEA,Schedules of Controlled Substances: Placement of Bromazolam in Schedule I  (DEA1420),Rulemaking,2025-12-15T15:47:54Z,0b000064b90d3674
DEA-2025-0555,DEA,Schedules of Controlled Substances: Placement of MDMB-4-PINACA in Schedule I (DEA1356),Rulemaking,2025-12-11T14:41:46Z,0b000064b8fefe20
DEA-2024-0144,DEA,Schedules of Controlled Substances: Placement of 4-Chloromethcathinone in Schedule I (DEA1246),Rulemaking,2025-11-19T21:13:12Z,0b00006486891ffe
DEA-2025-0557,DEA,Designation of P2P Methyl Glycidic Acid as a List I Chemical (DEA1395),Rulemaking,2025-11-04T12:07:45Z,0b000064b8fefe8d
DEA-2025-0588,DEA,"Schedules of Controlled Substances: Temporary Placement of ethyleneoxynitazene, methylenedioxynitazene, 5-methyl etodesnitazene, N-desethyl etonitazene, N-desethyl protonitazene, N,N-dimethylamino etonitazene, and N-pyrrolidino isotonitazene in Schedule I (DEA1494)",Rulemaking,2025-10-16T23:33:17Z,0b000064b9030281
DEA-2025-0192,DEA,"Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance  (DEA1390)",Rulemaking,2025-10-16T23:28:47Z,0b000064b8ec6630
DEA-2023-0016,DEA,Controlled Substances Ordering System Modernization (DEA732),Rulemaking,2025-10-02T21:31:46Z,0b0000648562ccb3
DEA-2025-0558,DEA,Requiring Online Submission of Applications for and Renewals of DEA Registration; Correction (DEA1111),Rulemaking,2025-10-02T21:30:04Z,0b000064b8fefe93
DEA-2024-0148,DEA,Schedules of Controlled Substances: Placement of Seven Specific Fentanyl-Related Substances in Schedule I of the Controlled Substances Act (DEA1457),Rulemaking,2025-10-02T21:28:47Z,0b00006486894bb0
DEA-2025-0556,DEA,"Specific Listing for 1-boc-4-piperidone, a Currently Controlled List I Chemical",Rulemaking,2025-10-02T21:22:21Z,0b000064b8fefe24
DEA-2024-0120,DEA,"Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025",Rulemaking,2025-09-19T16:15:52Z,0b00006486783c5d
DEA-2022-0145,DEA,"Schedules of Controlled Substances: Temporary Placement of Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and Diclazepam in Schedule I (DEA989)",Rulemaking,2025-08-27T12:33:24Z,0b0000648554cfe6
DEA-2024-0026,DEA,Placement of 2-Methyl AP-237 in Schedule I (DEA1245),Rulemaking,2025-07-28T18:22:10Z,0b00006486484632
DEA-2023-0148,DEA,Destruction Alternatives to Incineration (DEA1144),Rulemaking,2025-07-28T18:21:23Z,0b0000648618d50c
DEA-2025-0078,DEA,"Three specific fentanyl-related substances (para-bromofentanyl, para-fluoroacetyl fentanyl, and para-methyl acetyl fentanyl) (DEA1484)",Rulemaking,2025-07-28T18:18:20Z,0b000064b8dd586c
DEA-2023-0138,DEA,Designation of Propionyl Chloride as a List I Chemical (DEA1189),Rulemaking,2025-07-10T12:04:03Z,0b000064860bbba7
DEA-2025-0081,DEA,Placement of 3-methoxyphencyclidine (1-[1-(3-methoxyphenyl)cyclohexyl] piperidine) in Schedule I (DEA1146),Rulemaking,2025-07-10T11:56:30Z,0b000064b8ddd142
DEA-2023-0098,DEA,Implementation of the Designer Anabolic Steroid Control Act of 2014 (DEA481),Rulemaking,2025-07-07T16:45:39Z,0b00006485d9c470
DEA-2021-0003,DEA,Suspicious Orders of Controlled Substances,Rulemaking,2025-06-05T16:32:03Z,0b000064849e1a2e
DEA-2023-0028,DEA,Expansion of Induction of Buprenorphine via Telemedicine Encounter (DEA948),Rulemaking,2025-06-02T20:11:54Z,0b0000648572859f
DEA-2024-0059,DEA,Schedules of Controlled Substances: Rescheduling of Marijuana,Rulemaking,2025-02-21T15:51:02Z,0b0000648656cd99
DEA-2023-0168,DEA,"Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I (DEA1156)",Rulemaking,2025-02-21T15:50:53Z,0b00006486330ce3
DEA-2023-0150,DEA,"Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024 (DEA1228)",Rulemaking,2025-02-21T15:50:43Z,0b000064861df091
DEA-2024-0134,DEA,Control of Phenethyl Bromide as a List I Chemical (DEA1282),Rulemaking,2025-01-07T09:13:06Z,0b0000648683d06e
DEA-2021-0031,DEA,"Schedules of Controlled Substances: Temporary Placement of Butonitazene, Etodesnitazene, Flunitazene, Metodesnitazene, Metonitazene, N-pyrrolidino etonitazene, and Protonitazene in Schedule I",Rulemaking,2024-10-25T14:56:30Z,0b00006484ea7ed9
DEA-2023-0129,DEA,Placement of Ethylphenidate in Schedule I (DEA1142),Rulemaking,2024-10-24T10:27:34Z,0b00006485fe80fd
DEA-2023-0149,DEA,Placement of Zuranolone in Schedule IV (DEA1258),Rulemaking,2024-09-03T18:47:04Z,0b000064861a0975
DEA-2022-0058,DEA,"Providing CS to Ocean Vessels, Aircraft, and Other Entities",Rulemaking,2024-08-26T13:13:33Z,0b0000648514e942
DEA-2024-0009,DEA,Conforming Amendment Regarding the Veterinary Medicine Mobility Act of 2014,Rulemaking,2024-08-26T13:13:33Z,0b000064863e8464
DEA-2021-0027,DEA,Regulation of Telepharmacy Practice,Rulemaking,2024-08-26T13:06:55Z,0b00006484e57207
DEA-2020-0023,DEA,Implementation of the Agricultural Improvement Act,Rulemaking,2024-08-26T13:03:33Z,0b0000648481bb3b
DEA-2020-0031,DEA,Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act:  Dispensing and Administering Controlled Substances for Medication-Assisted Treatment,Rulemaking,2024-08-26T13:03:21Z,0b00006484946331
DEA-2020-0029,DEA,Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017,Rulemaking,2024-08-26T13:02:59Z,0b000064848b8dbc
DEA-2010-0010,DEA,Electronic Prescriptions for Controlled Substances,Rulemaking,2024-08-26T13:00:45Z,0b00006480acce59
DEA-2021-0005,DEA,Amending Regulations to Require Online Submission of Applications for and Renewals of DEA Registration,Rulemaking,2024-07-12T12:24:57Z,0b000064849e58a9
DEA-2021-0009,DEA,"MAPA - Designation as List I Chemical: Methyl alpha-phenylacetoacetate, a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine",Rulemaking,2024-06-11T01:13:26Z,0b00006484aeb507
DEA-2022-0120,DEA,"Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023",Rulemaking,2024-02-12T10:32:02Z,0b000064854169b8
DEA-2023-0169,DEA,Specific Listing for Three Currently Controlled Schedule I Substances (DEA1222),Rulemaking,2024-02-12T10:29:05Z,0b00006486330ce7
DEA-2023-0049,DEA,"Temporary Placement of MDMB-4en-PINACA, 4F-MDMB-BUTICA, ADB-4en-PINACA, CUMYL-PEGACLONE, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I (DEA1006)",Rulemaking,2023-12-12T10:13:43Z,0b000064858c4370
DEA-2023-0058,DEA,Placement of Nine Specific Fentanyl Related Substances in Schedule I (DEA1036),Rulemaking,2023-12-07T08:20:24Z,0b00006485946204
DEA-2023-0146,DEA,Additions to Listing of Exempt Chemical Mixtures (DEA1118),Rulemaking,2023-11-28T08:25:33Z,0b00006486128852
DEA-2023-0059,DEA,Designation as List I Chemicals: Halides of 4-Anilinopiperidine (DEA1098),Rulemaking,2023-10-31T09:33:44Z,0b00006485948761
DEA-2023-0106,DEA,Dispensing of Narcotic Drugs to Relieve Acute Withdrawal Symptoms of Opioid Use Disorder (DEA702),Rulemaking,2023-09-22T15:24:15Z,0b00006485e04d45
DEA-2019-0013,DEA,Management of Quotas for Controlled Substances and List I Chemicals,Rulemaking,2023-08-31T08:33:18Z,0b000064840ecddb
DEA-2021-0026,DEA,Transfer of Electronic Prescriptions for Controlled Substances for Initial Filling,Rulemaking,2023-07-27T17:35:24Z,0b00006484e3d5e0
DEA-2020-0035,DEA,Partial Filling of Prescriptions for Schedule II Controlled Substances,Rulemaking,2023-07-21T08:48:17Z,0b0000648498d6d9
DEA-2020-0038,DEA,Schedules of Controlled Substances: Placement of Brorphine in Schedule I,Rulemaking,2023-07-19T11:16:28Z,0b000064849c2716
DEA-2020-0022,DEA,Reporting of Theft or Significant Loss of Controlled Substances,Rulemaking,2023-06-22T11:34:57Z,0b000064847f5109
DEA-2023-0056,DEA,"Specific Listing for Eutylone, a Currently Controlled Schedule I Substance (DEA1003)",Rulemaking,2023-04-20T11:59:12Z,0b0000648591cd29
DEA-2022-0102,DEA,Designation of 4-Piperidone as a List I Chemical (DEA951),Rulemaking,2023-04-14T08:25:52Z,0b0000648532a5f2
DEA-2021-0013,DEA,Schedules of Controlled Substances:  Placement of Methiopropamine in Schedule I,Rulemaking,2023-01-03T10:35:25Z,0b00006484d9d986
DEA-2022-0137,DEA,"Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2023",Rulemaking,2022-12-02T09:49:04Z,0b00006485511272
DEA-2020-0027,DEA,"Default Provisions for Hearing Proceedings Relating to the Revocation, Suspension, or Denial of a Registration",Rulemaking,2022-11-30T08:08:19Z,0b000064848ac79e
DEA-2021-0012,DEA,Schedules of Controlled Substances: Placement of Mesocarb in Schedule I,Rulemaking,2022-11-22T08:27:38Z,0b00006484c6c390
DEA-2021-0025,DEA,Schedules of Controlled Substances: Removal of [18F]FP-CIT from Control,Rulemaking,2022-11-21T08:32:10Z,0b00006484e16b15
DEA-2020-0015,DEA,Schedules of Controlled Substances: Placement of Zipeprol in Schedule I,Rulemaking,2022-11-21T08:31:59Z,0b000064846acf98
DEA-2021-0011,DEA,Schedules of Controlled Substances: Placement of Amineptine in Schedule I,Rulemaking,2022-11-17T08:07:18Z,0b00006484c12765
DEA-2022-0134,DEA,"Specific Listing for 1-boc-4-AP, a Currently Controlled List I Chemical (DEA1046)",Rulemaking,2022-11-14T08:34:19Z,0b0000648549e00d
DEA-2022-0133,DEA,Technical Correction to Regulation Regarding Registration Exception for Officials,Rulemaking,2022-11-07T09:10:13Z,0b000064854931e9
DEA-2021-0014,DEA,"Aggregate Production  Quotas for Schedule I and II Controlled  Substances and Assessment of  Annual Needs for the List I Chemicals  Ephedrine, Pseudoephedrine, and  Phenylpropanolamine for 2022",Rulemaking,2022-11-01T08:26:20Z,0b00006484dc7d4f
DEA-2022-0025,DEA,Schedules of Controlled Substances: Placement of Daridorexant in Schedule IV,Rulemaking,2022-09-30T08:21:23Z,0b00006484fff734
DEA-2022-0026,DEA,"Schedules of Controlled Substances: Placement of 2,5-dimethoxy-4-iodoamphetamine (DOI) and 2,5-dimethoxy-4-chloroamphetamine (DOC) in Schedule I",Rulemaking,2022-09-13T08:49:45Z,0b0000648500a875
DEA-2022-0001,DEA,"Schedules of Controlled Substances: Placement of 4-hydroxy-N,N-diisopropyltryptamine, 5-methoxy-alpha-methyltryptamine, 5-methoxy-N-methyl-N-isopropyltryptamine, 5-methoxy-N,N-diethyltryptamine, and N,N-diisopropyltryptamine in Schedule I",Rulemaking,2022-07-27T08:21:18Z,0b00006484f21216
DEA-2021-0010,DEA,Schedules of Controlled Substances: Placement of Serdexmethylphenidate in Schedule IV,Rulemaking,2022-06-24T08:22:18Z,0b00006484b1ab60
DEA-2022-0027,DEA,Schedules of Controlled Substances: Exempted Prescription Products - Butalbital products,Rulemaking,2022-06-07T08:46:48Z,0b0000648500f7d4
DEA-2021-0030,DEA,Schedules of Controlled Substances: Placement of Methoxetamine in Schedule I,Rulemaking,2022-06-06T09:58:53Z,0b00006484ea7ed5
DEA-2019-0002,DEA,"Schedules of Controlled Substances: Placement of 5F-EDMBPINACA,
5F-MDMB-PICA, FUB-AKB48, 5F-CUMYL-PINACA, and FUB-144 in
Schedule I",Rulemaking,2022-04-08T08:28:19Z,0b00006483b714a4
DEA-2018-0002,DEA,Implementation of the Provision of the Comprehensive Addiction and Recovery Act of 2016 Relating to the Dispensing of Narcotic Drugs for Opioid Use Disorder,Rulemaking,2022-04-02T01:07:02Z,0b00006482e4b773
DEA-2018-0009,DEA,Schedules of Controlled Substances: Placement of beta-Hydroxythiofentanyl into Schedule I,Rulemaking,2022-04-02T01:07:02Z,0b00006483254c72
DEA-2014-0005,DEA,Schedules of Controlled Substances:  Rescheduling of Hydrocodone Combination Products from Schedule III to Schedule II,Rulemaking,2022-03-22T11:18:07Z,0b000064815b6cb3
DEA-2018-0004,DEA,"Schedules of Controlled Substances:
Placement of Butyryl Fentanyl and
U–47700 Into Schedule I (DEA-478)",Rulemaking,2022-03-22T11:16:58Z,0b0000648319a695
DEA-2021-0024,DEA,Adding Space Force to DEA Regulations,Rulemaking,2021-12-13T15:38:43Z,0b00006484e0408e
DEA-2020-0036,DEA,Supplier's Registration Number on the Single-Sheet DEA Form 222,Rulemaking,2021-12-13T15:35:55Z,0b000064849af553
DEA-2020-0005,DEA,Registration Requirements for Narcotic Treatment Programs with Mobile Components,Rulemaking,2021-12-13T15:33:40Z,0b000064843b54e5
DEA-2013-0002,DEA,Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV,Rulemaking,2021-12-02T01:01:29Z,0b000064812438ed
DEA-2013-0009,DEA,Schedules of Controlled Substances: Placement of Perampanel into Schedule III,Rulemaking,2021-12-02T01:01:29Z,0b000064814577a1
DEA-2013-0010,DEA,Schedules of Controlled Substances:  Placement of Tramadol into Schedule IV,Rulemaking,2021-12-02T01:01:29Z,0b0000648146f62c
DEA-2013-0011,DEA,"Schedules of Controlled Substances: Temporary Placement of Three Synthetic 
Phenethylamines into Schedule I",Rulemaking,2021-12-02T01:01:29Z,0b0000648147da34
DEA-2018-0006,DEA,"Schedules of Controlled Substances: Extension of Temporary Placement of Five Synthetic Cannabinoids Into Schedule I of the Controlled Substances Act, DEA-345",Rulemaking,2021-12-02T01:01:29Z,0b0000648321a7cd
DEA-2019-0007,DEA,Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control,Rulemaking,2021-12-02T01:01:29Z,0b00006483eaf996
DEA-2019-0003,DEA,"Interlocutory Appeals in Administrative
Hearings",Rulemaking,2021-12-02T01:00:59Z,0b00006483c17ccc
DEA-2019-0004,DEA,"Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I",Rulemaking,2021-12-02T01:00:59Z,0b00006483c8ada8
DEA-2019-0009,DEA,"Schedules of Controlled Substances: Temporary Placement of N-Ethylhexedrone, a-PHP, 4-MEAP, MPHP, PV8, and 4-Chloro-a-PVP in Schedule I",Rulemaking,2021-12-02T01:00:59Z,0b00006483f91d72
DEA-2019-0010,DEA,Listing of Noroxymorphone in the Code of Federal Regulations and Assignment of a Controlled Substances Code Number,Rulemaking,2021-12-02T01:00:59Z,0b00006483f94f85
DEA-2019-0011,DEA,"Schedules of Controlled Substances: Designation of Benzylfentanyl and 4-Anilinopiperidine, Precursor Chemicals Used in the Illicit Manufacture of Fentanyl, as List I Chemicals",Rulemaking,2021-12-02T01:00:59Z,0b00006483f94f89
DEA-2019-0012,DEA,Schedules of Controlled Substances: Control of the Immediate Precursor Norfentanyl Used in the Illicit Manufacture of Fentanyl as Schedule II,Rulemaking,2021-12-02T01:00:59Z,0b00006483f94f8d
DEA-2019-0014,DEA,"Schedules of Controlled Substances: Placement of Cyclopropyl Fentanyl, Methoxyacetyl fentanyl, ortho-Fluorofentanyl, and para-Fluorobutyryl Fentanyl in Schedule I",Rulemaking,2021-12-02T01:00:59Z,0b000064841fc599
DEA-2020-0004,DEA,Schedules of Controlled Substances: Removal of 6-beta-Naltrexol from Control,Rulemaking,2021-12-02T01:00:59Z,0b00006484322c50
DEA-2020-0014,DEA,Technical Correction to Regulation Regarding Registration,Rulemaking,2021-12-02T01:00:59Z,0b000064844bd097
DEA-2020-0017,DEA,Schedules of Controlled Substances: Placement of Isotonitazene in Schedule I,Rulemaking,2021-12-02T01:00:59Z,0b000064846f9f29